johnson kd, smith st, pouliot jd, miller ln. comparison of pharmacist- and provider-managed lithium in an inpatient medical center: a 6-month review. j am pharm assoc (2003). 2021;61(5):e103-e107. doi:10.1016/j.japh.2021.06.014
johnson kd, miller ln, pouliot jd, martin pr. retrospective analysis of oxcarbazepine in pregnant women with substance use disorders: focus on safety. j pharm pract. 2019. doi: 10.1177/0897190019850700
fuchs pa, isaacs da, schiff m, miller l, stovall j. severe extrapyramidal symptoms in a patient with niemann-pick type c disease after a long-acting injection of risperidone. j clin psychopharmacol. 2019;39(6):677-678. doi:10.1097/jcp.0000000000001119
miller ln, mercer sl. drugs of abuse and addiction: an integrated approach to teaching. curr pharm teach learn. 2017;9(3):405-414. doi: 10.1016/j.cptl.2017.01.003
mayberry km, miller ln. incidence of self-reported depression among pharmacy residents in tennessee. am j pharm educ. 2017;81(8):5960. doi: 10.5688/ajpe5960
boswell jc, lee jt, burghart sm, scholtes k, miller ln. medication reconciliation improvement in a private psychiatric inpatient hospital. mental health clinician. 2015;5(1):35-39. doi: 10.9740/mhc.2015.01.035